pacira-bioscience-logO.png
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
10 oct. 2023 08h00 HE | Pacira BioSciences
-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the...
pacira-bioscience-logO.png
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
02 oct. 2023 08h00 HE | Pacira BioSciences
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5...
pacira-bioscience-logO.png
Pacira BioSciences Announces Leadership Succession Plan
26 sept. 2023 16h30 HE | Pacira BioSciences
David Stack to Retire as Chairman and CEO Once Successor is Appointed Board Has Initiated Search for Successor TAMPA, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq:...
pacira-bioscience-logO.png
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
06 sept. 2023 08h00 HE | Pacira BioSciences
TAMPA, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced its participation in an analyst-led fireside chat at the H.C. Wainwright 25th Annual Global...
pacira-bioscience-logO.png
Pacira BioSciences Reports Second Quarter 2023 Financial Results
02 août 2023 08h00 HE | Pacira BioSciences
-- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain...
pacira-bioscience-logO.png
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
26 juil. 2023 08h00 HE | Pacira BioSciences
TAMPA, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on...
pacira-bioscience-logO.png
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
31 mai 2023 08h00 HE | Pacira BioSciences
TAMPA, Fla., May 31, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 Jefferies Healthcare...
pacira-bioscience-logO.png
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
09 mai 2023 08h00 HE | Pacira BioSciences
TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 RBC Capital Markets Global...
pacira-bioscience-logO.png
Pacira BioSciences Reports First Quarter 2023 Financial Results
03 mai 2023 08h00 HE | Pacira BioSciences
-- EXPAREL continues to outperform elective surgery market with average daily volumes up 6 percent over prior year -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., May 03, 2023 (GLOBE...
pacira-bioscience-logO.png
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
26 avr. 2023 08h00 HE | Pacira BioSciences
TAMPA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on...